Home

Home

Designed for bariatrics

Berchtold markets a multi-specialty surgical table that can articulate heavyweight patients yet maintain necessary height.

article image
The manufacturer reports that its Operon D 850 will:

- lift and articulate 450 kg throughout its entire motion range
- go lower than any other surgical table on the market, at 563 mm
- rise to a maximum table-top height of 1179 mm.

The table’s 420 mm longitudinal slide, carbon fibre table top and integrated X-ray cassette channel provide a platform for all types of imaging, and the removable head, back and leg sections enable customisation for all surgical procedures, Berchtold points out.

article image
Special castors and the optional autodrive also ease movement between rooms.

This article was published on 07/08/2007

Search

 

Service

Company News

Carestream: technical infrastructure for EU funded R-bay project

Carestream Health is a major technical infrastructure provider to the EU-funded R-Bay validation project, which aims to address the uneven spread of radiologists across member states. CARESTREAM Radiology and Information Management Solutions are driving the initial test platform for the project by facilitating remote reporting of images from hospitals in Denmark, Finland and Czech Republic by clinical providers in Estonia, Lithuania and the Netherlands.

Accu-Chek® Combo – put effective diabetes management into action

At the annual congress of the European Association for the Study of Diabetes (EASD) this year in Rome, Roche Diabetes Care introduced Accu-Chek Combo – the insulin pump system that combines an insulin pump with an intelligent glucose monitoring system, a bolus calculator, and an integrated pump remote-control.

Insulin in oral capsules

At the international congress on diabetes in September, Oramed Pharmaceuticals, Inc. introduced its oral insulin capsules that might in the future replace injections patients currently have to face. Last week Oramed announced the agreement with ETI Karle Clinical Pvt. Ltd. to conduct phase 2B clinical trials for its oral insulin capsules.